Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...

A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

Biotech startups generally rely on small business innovation grants to develop their technology. The Trump administration's ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...

Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...

Chrystal Starbird, a cancer researcher at the University of North Carolina School of Medicine, had been preparing to serve on ...

"We need to know what adverse events are. We need to understand the safety of every drug, mifepristone, and every other drug.